Giving gentamicin once daily for neutropenic fever has proved to be simple

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7055.490a (Published 24 August 1996) Cite this as: BMJ 1996;313:490
  1. R P D Cooke, Consultant medical microbiologist,
  2. R J Grace, Consultant haematologist,
  3. P A Gover, Consultant haematologist
  1. District General Hospital, Eastbourne, East Sussex BN21 2UD

    EDITOR,—Michael Barza and colleagues' meta-analysis of single versus multiple daily doses of aminoglycosides1 confirms the view that once daily dosing is safe and clinically effective.2 However, specific experience with gentamicin (the most commonly prescribed aminoglycoside in Britain) is extremely limited because most trials have compared either netilimicin or amikacin.1 Only three trials of aminoglycosides in the management of febrile neutropenic patients were referenced, none of which used gentamicin. Haematology units that treat neutropenic fever with gentamicin may therefore be reluctant …

    View Full Text

    Sign in

    Log in through your institution